Invests in and holds stakes in medical research and development companies, particularly in digital health, intending to earn returns by improving those holdings and realising them through sales to third parties or public offerings.
Geographic Exposure
IsraelN/A
Revenue Drivers
End Markets
Third-party acquirers of portfolio holdings
Public market investors in portfolio company offerings
Specializations
Digital health investment focusHoldings in quantum-computing drug designHoldings in AI clinical-data disease modellingHoldings in wearable migraine treatment devicesHoldings in portable electrospinning wound careHolding in cyber-security asset management+1 more
